Alpha tropomyosin as a self-antigen in patients with Behcet's disease

被引:37
作者
Mahesh, SP
Li, ZQ
Buggage, R
Mor, F
Cohen, IR
Chew, EY
Nussenblatt, RB
机构
[1] NEI, Immunol Lab, Bethesda, MD 20892 USA
[2] NEI, Div Epidemiol & Clin Res, Bethesda, MD 20892 USA
[3] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
alpha tropomyosin; autoantigen; autoantibody; Behcet's disease;
D O I
10.1111/j.1365-2249.2005.02760.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report for the first time a significant increased lymphoproliferative response to alpha tropomyosin as well as observing autoantibodies to tropomyosin observed in Behcet's disease (BD) patients with posterior uveitis. Peripheral blood mononuclear cells (PBMCs) from 18 BD patients with posterior uveitis, 18 patients with other forms of noninfectious uveitis, 9 patients with retinal damage due to photocoagulation as well as 18 healthy donors were evaluated for antigen-specific lymphoproliferative responses to alpha tropomyosin and its derivative peptides. The proliferative responses of PBMCs to these antigens were studied using H-3 thymidine incorporation assay. Serum samples were also screened by ELISA for autoantibodies against tropomyosin. Six of the 18 (33%) BD patients with posterior uveitis showed increased proliferative response to alpha tropomyosin or its derivative peptides, while none of the healthy, disease controls were positive. The mean lymphoproliferative responses to tropomyosin were significantly higher (P < 0.02) in the BD patients compared to healthy or disease controls. Higher titres of anti-tropomyosin antibodies were also seen in four of the 18 BD patients but none in the healthy or disease control groups (P < 0.002). The occurrence of these abnormalities supports a possible role for alpha tropomyosin as a self-antigen in a subset of patients with Behcet's disease.
引用
收藏
页码:368 / 375
页数:8
相关论文
共 25 条
[1]  
Biancone L, 1998, CLIN EXP IMMUNOL, V113, P198
[2]   INTERNATIONAL-UVEITIS-STUDY-GROUP RECOMMENDATIONS FOR THE EVALUATION OF INTRAOCULAR INFLAMMATORY DISEASE [J].
BLOCHMICHEL, E ;
NUSSENBLATT, RB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 103 (02) :234-235
[3]  
CASPI RR, 1988, J IMMUNOL, V140, P1490
[4]  
DAS KM, 1993, J IMMUNOL, V150, P2478
[5]  
de Smet MD, 2000, INVEST OPHTH VIS SCI, V41, P3480
[6]  
DIGHIERO G, 1990, CLIN EXP IMMUNOL, V82, P52
[7]   ANTIENDOTHELIAL CELL ANTIBODIES, ENDOTHELIAL PROLIFERATION AND VON-WILLEBRAND-FACTOR ANTIGEN IN BEHCETS-DISEASE [J].
DIRESKENELI, H ;
KESER, G ;
DCRUZ, D ;
KHAMASHTA, MA ;
AKOGLU, T ;
YAZICI, H ;
YURDAKUL, S ;
HAMURYUDAN, V ;
OZGUN, S ;
GORAL, AJ ;
HUGHES, GRV .
CLINICAL RHEUMATOLOGY, 1995, 14 (01) :55-61
[8]  
Direskeneli H, 2000, J RHEUMATOL, V27, P708
[9]  
FENDERSON PG, 1989, J IMMUNOL, V142, P2475
[10]  
GALLOWAY PG, 1990, AM J PATHOL, V137, P291